Nathan B Pliam

Title: Nathan B Pliam: Innovator in Immunotherapy

Introduction

Nathan B Pliam is a notable inventor based in Palo Alto, California. He has made significant contributions to the field of immunotherapy, particularly in the development of compositions and methods for immunosuppression therapy. With a total of two patents to his name, Pliam's work is paving the way for advancements in medical treatments.

Latest Patents

Pliam's latest patents include an "Immunotherapy composition and method" and an "Immunosuppressant diterpene compound." The first patent discloses a composition for use in immunosuppression therapy, which includes an immunosuppressant drug, such as cyclosporin A, combined with an ethanol extract of the root xylem of Tripterygium wilfordii. This extract is effective in treating transplantation rejection, either alone or in combination with the immunosuppressant. The second patent describes an immunosuppressant compound that can be produced by culturing Fusarium subglutinans f. sp. tripterygii, isolated from the stems of Tripterygium wilfordii. This compound is intended for use in pharmaceutical compositions for immunosuppression therapy.

Career Highlights

Nathan B Pliam is currently associated with Pharmagenesis, Inc., where he continues to innovate in the field of immunotherapy. His work is characterized by a strong focus on developing effective treatments for patients requiring immunosuppression.

Collaborations

Pliam has collaborated with notable colleagues, including Tien-Wen Tao Wiedmann and Jian Wang. These collaborations have contributed to the advancement of his research and the development of his patents.

Conclusion

Nathan B Pliam is a distinguished inventor whose work in immunotherapy is making a significant impact in the medical field. His innovative patents reflect his commitment to improving treatment options for patients in need of immunosuppression therapy.